Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Brain Neoplasms × Methylprednisolone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia 44 Lymphoma 37 Precursor Cell Lymphoblastic Leukemia-Lymphoma 36 Myelodysplastic Syndromes 28 Lymphoma, Non-Hodgkin 26 Lymphoma, Large B-Cell, Diffuse 24 Leukemia, Myeloid, Acute 24 Lymphoma, Follicular 23 Leukemia, Myeloid, Chronic-Phase 22 Leukemia, Lymphocytic, Chronic, B-Cell 21 Burkitt Lymphoma 21 Leukemia, Myeloid, Accelerated Phase 20 Lymphoma, Large-Cell, Immunoblastic 19 Multiple Myeloma 18 Myeloproliferative Disorders 17 Hodgkin Disease 17 Blast Crisis 17 Neoplasms, Plasma Cell 16 Graft vs Host Disease 16 Lymphoma, Mantle-Cell 15 Lymphoma, B-Cell, Marginal Zone 15 Leukemia, Myelomonocytic, Chronic 15 Dendritic Cell Sarcoma, Interdigitating 14 Recurrence 12 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 12 Primary Myelofibrosis 11 Congenital Abnormalities 11 Anemia, Refractory, with Excess of Blasts 11 Myelodysplastic-Myeloproliferative Diseases 10 Lymphoma, T-Cell, Cutaneous 9

Interventions

Radiosurgery 104 Temozolomide 94 Bevacizumab 64 Magnetic Resonance Spectroscopy 62 Radiotherapy 60 Carboplatin 29 pembrolizumab 26 Irinotecan 24 Surgical Procedures, Operative 22 Nivolumab 22 Etoposide 20 Radiation 19 Magnetic Resonance Imaging 19 Ipilimumab 19 Erlotinib Hydrochloride 19 Cyclophosphamide 19 Surveys and Questionnaires 18 Aminolevulinic Acid 18 Specimen Handling 15 Pemetrexed 15 Mental Status and Dementia Tests 14 Cisplatin 14 Topotecan 13 Carmustine 13 Neuropsychological Tests 12 Drug Therapy 11 Trastuzumab 10 Saline Solution 10 Imatinib Mesylate 10 Gefitinib 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05789589 2026-03-04

ADORATION

Baptist Health South Florida

Phase 1/2 Recruiting

Brain Neoplasms, Neoplasm Metastasis, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡